Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neurocrine Bioscienc (NBIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,277,452
  • Shares Outstanding, K 90,682
  • Annual Sales, $ 161,630 K
  • Annual Income, $ -142,540 K
  • 36-Month Beta 1.18
  • Price/Sales 20.63
  • Price/Cash Flow N/A
  • Price/Book 17.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.13
  • Number of Estimates 10
  • High Estimate 0.24
  • Low Estimate 0.05
  • Prior Year 0.07
  • Growth Rate Est. (year over year) +85.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.71 +31.99%
on 12/24/18
92.71 -5.03%
on 01/23/19
+18.03 (+25.75%)
since 12/21/18
3-Month
64.72 +36.05%
on 12/12/18
116.25 -24.26%
on 11/02/18
-20.51 (-18.89%)
since 10/23/18
52-Week
64.72 +36.05%
on 12/12/18
126.98 -30.66%
on 09/13/18
+0.18 (+0.20%)
since 01/23/18

Most Recent Stories

More News
4 Defensive Stocks to Buy Amid Shutdown and Brexit

Defensive equities could ride out market unpredictability.

NWL : 20.20 (-1.42%)
NBIX : 88.03 (-3.56%)
IONS : 56.95 (-0.85%)
TUP : 37.43 (+0.67%)
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2018 financial results after the Nasdaq market closes on Tuesday, Feb. 5, 2019. Neurocrine will...

NBIX : 88.03 (-3.56%)
After Yesterday's Rally of 4.06% Shares Could Potentially Pullback

Neurocrine Biosc (NASDAQ:NBIX) traded in a range yesterday that spanned from a low of $82.87 to a high of $85.40. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high...

NBIX : 88.03 (-3.56%)
Neurocrine Gives Ingrezza Sales View, Updates on Pipeline

Neurocrine (NBIX) issues preliminary sales outlook for Ingrezza with respect to the fourth quarter of 2018 as well as the full year. The company also lends an update on its pipeline.

NBIX : 88.03 (-3.56%)
HKMPF : 19.8000 (-7.48%)
ABBV : 88.38 (-0.32%)
BSTC : 62.31 (-2.40%)
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2018 Net Product Sales Results and 2019 Program Milestones

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today provided an update on its business performance, including preliminary net product sales results for 2018, and key clinical development programs for 2019....

JPM : 102.33 (-0.59%)
NBIX : 88.03 (-3.56%)
Neurocrine Biosciences to Present at the 37th Annual J.P. Morgan Healthcare Conference

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 37th Annual J.P. Morgan Healthcare Conference at 2:30 p.m. PT (5:30 p.m. ET) on Monday, Jan. 7, 2019, in San Francisco. Kevin Gorman, Chief...

JPM : 102.33 (-0.59%)
NBIX : 88.03 (-3.56%)
38.5% Return Seen to Date on SmarTrend Neurocrine Biosc Call (NBIX)

SmarTrend identified a Downtrend for Neurocrine Biosc (NASDAQ:NBIX) on October 5th, 2018 at $115.36. In approximately 3 months, Neurocrine Biosc has returned 38.45% as of today's recent price of $71.00....

NBIX : 88.03 (-3.56%)
Neurocrine Biosc Has Returned 38.9% Since SmarTrend Recommendation (NBIX)

SmarTrend identified a Downtrend for Neurocrine Biosc (NASDAQ:NBIX) on October 5th, 2018 at $115.36. In approximately 2 months, Neurocrine Biosc has returned 38.87% as of today's recent price of $70.52....

NBIX : 88.03 (-3.56%)
Do Options Traders Know Something About Neurocrine Biosciences (NBIX) Stock We Don't?

Investors need to pay close attention to Neurocrine Biosciences (NBIX) stock based on the movements in the options market lately.

NBIX : 88.03 (-3.56%)
Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Synergy Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / December 13, 2018 / Shares of both Neurocrine Biosciences and Synergy Pharmaceuticals were in the red on Wednesday after announcing discouraging developments. Synergy is selling...

NBIX : 88.03 (-3.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade NBIX with:

Business Summary

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding...

See More

Key Turning Points

2nd Resistance Point 92.59
1st Resistance Point 91.94
Last Price 88.03
1st Support Level 90.10
2nd Support Level 88.92

See More

52-Week High 126.98
Fibonacci 61.8% 103.20
Fibonacci 50% 95.85
Fibonacci 38.2% 88.50
Last Price 88.03
52-Week Low 64.72

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar